ExomeDNA is committed to protecting your genetic data with industry-leading security practices and compliance with international data protection regulations.
Last Security Audit: November 2025
Supabase Row-Level Security (RLS) policies ensure users can ONLY access their own genetic data:
Status: Supported via Supabase Auth (TOTP - Time-based One-Time Password)
Recommendation: Enable MFA in your account settings for enhanced security
Latest Audit: November 2025
Comprehensive 1,084-line security audit covering authentication, API security, infrastructure, code security, and GDPR compliance.
0
Critical Issues
0
High-Priority Issues
2
Medium Recommendations
1
Low-Priority Fixes
🔒 Responsible Disclosure Program
If you discover a security vulnerability in ExomeDNA, please report it responsibly. We appreciate your help in keeping our users' genetic data safe.
Status: Under consideration (not currently offered)
For now, we appreciate responsible disclosure and will publicly acknowledge security researchers who report valid vulnerabilities (with permission).
Important Disclaimer: ExomeDNA is NOT a medical device and is NOT FDA-cleared. Our genetic analysis is for educational and research purposes only.
Security Questions: security@exomedna.com
Privacy Questions: support@exomedna.com
General Support: support@exomedna.com
Response Time: Security issues: 48 hours | General inquiries: 3-5 business days
Last Updated: November 2025
Next Audit: February 2026 (Quarterly Schedule)